Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $2.16 Analyst target: $13.25 Upside: 513.43%
Alterity Therapeutics Limited researches and develops therapeutic drugs for the treatment of Parkinson's disease and other neurodegenerative diseases in Australia. The company is headquartered in Melbourne, Australia.
See the full interactive analysis & chart →Informational only — not investment advice.